Meili Pei

277 West Yanta Road
Xi'an, 710061, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

STAT1β modulates the tumor immune microenvironment to improve prognosis in ovarian cancer: a comprehensive study of transcriptional and protein expression differences.

STAT1β modulates the tumor immune microenvironment to improve prognosis in ovarian cancer: a comprehensive study of transcriptional and protein expression differences.

Journal: Journal of ovarian research

Published: May 05, 2025

FAM64A contributes to ovarian cancer proliferation and metastasis by suppressing TWIST1 ubiquitination and degradation.

FAM64A contributes to ovarian cancer proliferation and metastasis by suppressing TWIST1 ubiquitination and degradation.

Journal: Endocrine-related cancer

Published: March 07, 2025

Lnc-THAP7-AS1 suppresses the ovarian cancer progression by targeting miR-92b-5p/fatty acid 2-hydroxylase signal axis.

Lnc-THAP7-AS1 suppresses the ovarian cancer progression by targeting miR-92b-5p/fatty acid 2-hydroxylase signal axis.

Journal: Translational oncology

Published: December 10, 2024

LncRNA ABHD11-AS1 activates EGFR signaling to promote cervical cancer progression by preventing FUS-mediated degradation of ABHD11 mRNA.

LncRNA ABHD11-AS1 activates EGFR signaling to promote cervical cancer progression by preventing FUS-mediated degradation of ABHD11 mRNA.

Journal: Cell cycle (Georgetown, Tex.)

Published: December 26, 2023

The up-regulation of PAK2 indicates unfavorable prognosis in patients with serous epithelial ovarian cancer and contributes to paclitaxel resistance in ovarian cancer cells.

The up-regulation of PAK2 indicates unfavorable prognosis in patients with serous epithelial ovarian cancer and contributes to paclitaxel resistance in ovarian cancer cells.

Journal: BMC cancer

Published: October 28, 2023

miR-145 inhibits mitochondrial function of ovarian cancer by targeting ARL5B.

miR-145 inhibits mitochondrial function of ovarian cancer by targeting ARL5B.

Journal: Journal of ovarian research

Published: November 06, 2020

YTHDF2, a protein repressed by miR-145, regulates proliferation, apoptosis, and migration in ovarian cancer cells.

YTHDF2, a protein repressed by miR-145, regulates proliferation, apoptosis, and migration in ovarian cancer cells.

Journal: Journal of ovarian research

Published: June 03, 2020

Berberine inhibits the Warburg effect through TET3/miR-145/HK2 pathways in ovarian cancer cells.

Berberine inhibits the Warburg effect through TET3/miR-145/HK2 pathways in ovarian cancer cells.

Journal: Journal of Cancer

Published: May 30, 2020

Assessment of endometrial receptivity during implantation window in women with unexplained infertility.

Assessment of endometrial receptivity during implantation window in women with unexplained infertility.

Journal: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology

Published: February 20, 2020

Berberine inhibited metastasis through miR-145/MMP16 axis in vitro.

Berberine inhibited metastasis through miR-145/MMP16 axis in vitro.

Journal: Journal of ovarian research

Published: February 02, 2020

Evaluation of Risk Factors for Venous Thromboembolism in Patients Who Underwent Gynecological Surgery and Validation of a Fast-Rating Assessment Table.

Evaluation of Risk Factors for Venous Thromboembolism in Patients Who Underwent Gynecological Surgery and Validation of a Fast-Rating Assessment Table.

Journal: Medical science monitor : international medical journal of experimental and clinical research

Published: November 22, 2019

Luteal blood flow as a predictive factor for methotrexate treatment outcomes in women with unruptured tubal pregnancy.

Luteal blood flow as a predictive factor for methotrexate treatment outcomes in women with unruptured tubal pregnancy.

Journal: BMC pregnancy and childbirth

Published: October 21, 2019

Showing 1-12 of 27

Last Updated: 09/26/2026